ADULT T-CELL LEUKEMIA/LYMPHOMA
Clinical trials for ADULT T-CELL LEUKEMIA/LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADULT T-CELL LEUKEMIA/LYMPHOMA trials appear
Sign up with your email to follow new studies for ADULT T-CELL LEUKEMIA/LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for rare blood cancer
Disease control CompletedThis study tested a drug called belinostat combined with zidovudine (AZT) as a follow-up treatment for people with adult T-cell leukemia-lymphoma (ATLL), a rare and aggressive blood cancer. The goal was to see if this combination could clear cancer cells from the blood and keep t…
Matched conditions: ADULT T-CELL LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated May 26, 2026 07:59 UTC
-
New hope for Hard-to-Treat lymphoma: targeted drug shows promise even when marker levels are low
Disease control CompletedThis study tested a drug called brentuximab vedotin in 23 people with a type of blood cancer (T-cell lymphoma) that had stopped responding to or returned after previous chemotherapy. The drug is designed to seek out and kill cancer cells that have a specific marker called CD30, e…
Matched conditions: ADULT T-CELL LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: Deepa Jagadeesh • Aim: Disease control
Last updated May 26, 2026 07:26 UTC